Description: Die PHOENIX group ist ein führender Pharmahändler in Europa. Das Unternehmen bietet heute mit 26 Ländern eine europaweit einzigartige Flächenabdeckung.
The company has set an official target to become CO 2 -neutral in its own business operations by the year 2030. We want to avoid and reduce our emissions by at least 30 per cent (Scope 1 + 2 emissions). PHOENIX thereby underlines its commitment to creating added value for society and the environment beyond our mission in the healthcare sector.
For fiscal year 2022/23 (31 January 2023), the PHOENIX group has once again presented solid key financial figures in a challenging environment. Strengthened by the completion of the acquisition of parts of McKesson Europe, the healthcare provider has further expanded its leading position in Europe.
The PHOENIX group has completed the acquisition of parts of McKesson Europe, following the clearance by competition authorities of the full scope of the transaction. The closing took place on 31 October 2022.